These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

363 related items for PubMed ID: 29047417

  • 21. Impact of prophylactic administration of Levosimendan on short-term and long-term outcome in high-risk patients with severely reduced left-ventricular ejection fraction undergoing cardiac surgery - a retrospective analysis.
    Grieshaber P, Lipp S, Arnold A, Görlach G, Wollbrück M, Roth P, Niemann B, Wilhelm J, Böning A.
    J Cardiothorac Surg; 2016 Dec 01; 11(1):162. PubMed ID: 27906091
    [Abstract] [Full Text] [Related]

  • 22. A randomized controlled trial of levosimendan to reduce mortality in high-risk cardiac surgery patients (CHEETAH): Rationale and design.
    Zangrillo A, Alvaro G, Pisano A, Guarracino F, Lobreglio R, Bradic N, Lembo R, Gianni S, Calabrò MG, Likhvantsev V, Grigoryev E, Buscaglia G, Pala G, Auci E, Amantea B, Monaco F, De Vuono G, Corcione A, Galdieri N, Cariello C, Bove T, Fominskiy E, Auriemma S, Baiocchi M, Bianchi A, Frontini M, Paternoster G, Sangalli F, Wang CY, Zucchetti MC, Biondi-Zoccai G, Gemma M, Lipinski MJ, Lomivorotov VV, Landoni G.
    Am Heart J; 2016 Jul 01; 177():66-73. PubMed ID: 27297851
    [Abstract] [Full Text] [Related]

  • 23. The effects of levosimendan in cardiac surgery patients with poor left ventricular function.
    De Hert SG, Lorsomradee S, Cromheecke S, Van der Linden PJ.
    Anesth Analg; 2007 Apr 01; 104(4):766-73. PubMed ID: 17377079
    [Abstract] [Full Text] [Related]

  • 24. Levosimendan Reduces Mortality and Low Cardiac Output Syndrome in Cardiac Surgery.
    Weber C, Esser M, Eghbalzadeh K, Sabashnikov A, Djordjevic I, Maier J, Merkle J, Choi YH, Madershahian N, Liakopoulos O, Deppe AC, Wahlers TCW.
    Thorac Cardiovasc Surg; 2020 Aug 01; 68(5):401-409. PubMed ID: 31770777
    [Abstract] [Full Text] [Related]

  • 25. Use of Levosimendan in Postoperative Setting After Surgical Repair of Congenital Heart Disease in Children.
    Amiet V, Perez MH, Longchamp D, Boulos Ksontini T, Natterer J, Plaza Wuthrich S, Cotting J, Di Bernardo S.
    Pediatr Cardiol; 2018 Jan 01; 39(1):19-25. PubMed ID: 28884218
    [Abstract] [Full Text] [Related]

  • 26. Levosimendan improves renal outcome in cardiac surgery: a randomized trial.
    Baysal A, Yanartas M, Dogukan M, Gundogus N, Kocak T, Koksal C.
    J Cardiothorac Vasc Anesth; 2014 Jun 01; 28(3):586-94. PubMed ID: 24447501
    [Abstract] [Full Text] [Related]

  • 27. Levosimendan in paediatric cardiac anaesthesiology: A systematic review and meta-analysis.
    Lapere M, Rega F, Rex S.
    Eur J Anaesthesiol; 2022 Aug 01; 39(8):646-655. PubMed ID: 35792892
    [Abstract] [Full Text] [Related]

  • 28. Prospective observational study of levosimendan and weaning of difficult-to-wean ventilator dependent intensive care patients.
    Sterba M, Banerjee A, Mudaliar Y.
    Crit Care Resusc; 2008 Sep 01; 10(3):182-6. PubMed ID: 18798715
    [Abstract] [Full Text] [Related]

  • 29. Predictors and associated clinical outcomes of low cardiac output syndrome following cardiac surgery: insights from the LEVO-CTS trial.
    Kochar A, Zheng Y, van Diepen S, Mehta RH, Westerhout CM, Mazer DC, Duncan AI, Whitlock R, Lopes RD, Argenziano M, de Varennes B, Alexander JH, Goodman SG, Fremes S.
    Eur Heart J Acute Cardiovasc Care; 2022 Nov 30; 11(11):818-825. PubMed ID: 36156131
    [Abstract] [Full Text] [Related]

  • 30. Five-year mortality in cardiac surgery patients with low cardiac output syndrome treated with levosimendan: prognostic evaluation of NT-proBNP and C-reactive protein.
    Torrado H, Lopez-Delgado JC, Farrero E, Rodríguez-Castro D, Castro MJ, Periche E, Carriò ML, Toscano JE, Pinseau A, Javierre C, Ventura JL.
    Minerva Cardioangiol; 2016 Apr 30; 64(2):101-13. PubMed ID: 26977768
    [Abstract] [Full Text] [Related]

  • 31. Mechanisms of a reduced cardiac output and the effects of milrinone and levosimendan in a model of infant cardiopulmonary bypass.
    Stocker CF, Shekerdemian LS, Nørgaard MA, Brizard CP, Mynard JP, Horton SB, Penny DJ.
    Crit Care Med; 2007 Jan 30; 35(1):252-9. PubMed ID: 17133188
    [Abstract] [Full Text] [Related]

  • 32. Levosimendan versus an intra-aortic balloon pump in adult cardiac surgery patients with low cardiac output.
    Elahi MM, Lam J, Asopa S, Matata BM.
    J Cardiothorac Vasc Anesth; 2011 Dec 30; 25(6):1154-62. PubMed ID: 21376634
    [No Abstract] [Full Text] [Related]

  • 33. Preoperative levosimendan in heart failure patients undergoing noncardiac surgery.
    Katsaragakis S, Kapralou A, Markogiannakis H, Kofinas G, Theodoraki EM, Larentzakis A, Menenakos E, Theodorou D.
    Neth J Med; 2008 Apr 30; 66(4):154-9. PubMed ID: 18424862
    [Abstract] [Full Text] [Related]

  • 34. [The calcium sensitizer levosimendan gives superior results to dobutamine in postoperative low cardiac output syndrome].
    Levin RL, Degrange MA, Porcile R, Salvagio F, Blanco N, Botbol AL, Tanus E, del Mazo CD.
    Rev Esp Cardiol; 2008 May 30; 61(5):471-9. PubMed ID: 18462650
    [Abstract] [Full Text] [Related]

  • 35. Levosimendan in patients with low cardiac output syndrome undergoing cardiac surgery: A systematic review and meta-analysis.
    Zhu J, Zhang Y, Chen L, He Y, Qing X.
    Anaesth Crit Care Pain Med; 2019 Jun 30; 38(3):243-249. PubMed ID: 30342103
    [Abstract] [Full Text] [Related]

  • 36. Study of levosimendan during off-pump coronary artery bypass grafting in patients with LV dysfunction: a double-blind randomized study.
    Shah B, Sharma P, Brahmbhatt A, Shah R, Rathod B, Shastri N, Patel J, Malhotra A.
    Indian J Pharmacol; 2014 Jun 30; 46(1):29-34. PubMed ID: 24550581
    [Abstract] [Full Text] [Related]

  • 37. Perioperative levosimendan therapy is associated with a lower incidence of acute kidney injury after cardiac surgery: a meta-analysis.
    Niu ZZ, Wu SM, Sun WY, Hou WM, Chi YF.
    J Cardiovasc Pharmacol; 2014 Feb 30; 63(2):107-12. PubMed ID: 24126568
    [Abstract] [Full Text] [Related]

  • 38. Prophylactic treatment with levosimendan: a retrospective matched-control study of patients with reduced left ventricular function.
    Kolseth SM, Nordhaug DO, Stenseth R, Sellevold O, Kirkeby-Garstad I, Wahba A.
    Eur J Cardiothorac Surg; 2009 Dec 30; 36(6):1024-30. PubMed ID: 19592266
    [Abstract] [Full Text] [Related]

  • 39. Levosimendan: new indications and evidence for reduction in perioperative mortality?
    Pisano A, Monti G, Landoni G.
    Curr Opin Anaesthesiol; 2016 Aug 30; 29(4):454-61. PubMed ID: 27168089
    [Abstract] [Full Text] [Related]

  • 40. Preoperative levosimendan infusion in combined aortic valve and coronary bypass surgery.
    Leppikangas H, Järvelä K, Sisto T, Maaranen P, Virtanen M, Lehto P, Karlsson S, Kööbi T, Lindgren L.
    Br J Anaesth; 2011 Mar 30; 106(3):298-304. PubMed ID: 21258075
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 19.